Lung Neoplasms with Low F18-Fluorodeoxyglucose Avidity

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• F18-fluorodeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) is a key imaging modality in oncology.
• However, certain malignant lung neoplasms exhibit low or absent FDG avidity, complicating interpretation.

Purpose of the Study:

• To investigate the factors influencing low FDG avidity in malignant lung neoplasms.
• To identify specific lung cancer subtypes and characteristics associated with reduced FDG uptake on PET/CT.

Main Methods:

• Review of imaging findings from patients with malignant lung neoplasms undergoing FDG PET/CT.
• Correlation of FDG uptake patterns with histopathologic type, clinical stage, and lesion characteristics.

Main Results:

• Malignant lung neoplasms can show variable FDG uptake, with some demonstrating low or absent avidity.
• Pathologic type (e.g., adenocarcinoma in situ, carcinoid) and clinical stage are independent predictors of FDG avidity.
• Small lesion size, leading to partial volume effects, and specific morphologies like subsolid nodules or ground-glass opacity are associated with false-negative PET findings.

Conclusions:

• Low FDG avidity in lung malignancies is influenced by tumor type, stage, size, and morphology.
• These factors can lead to false-negative results on FDG PET/CT, necessitating careful consideration of imaging characteristics.